SCOTT GREENSPAHN: Open Payments
NPI 1265665293 · BURIEN, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$395 in 21 payments from 11 companies in 2025. Trend: 2023 $94 · 2024 $434 · 2025 $395
Food & beverage: $395
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $101 |
| Orexo US, Inc. | 5 | $78 |
| Lilly USA, LLC | 3 | $61 |
| Novo Nordisk Inc | 1 | $25 |
| Kowa Pharmaceuticals America, Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Abbott Laboratories | 1 | $19 |
| Bausch Health US, LLC | 1 | $18 |
| Braeburn Inc. | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: XIFAXAN, Zubsolv, MOUNJARO, Wegovy, ZORYVE, TZIELD, FREESTYLE LIBRE 3, APLENZIN.
Industry payments across WA — which companies pay providers there.
